Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Neurooncol. 2019 Jan 17;142(2):319–325. doi: 10.1007/s11060-019-03099-x

Table 1.

Clinical data on prostatic cancer patients with CNS metastases

Case
No.
Site Years after
diagnosis
presenting
with CNS
metastases
Bony
metastases
Castrate-
resistant at
time of
dural/brain
metastasis
Prior treatment
1 C6-T1 (Dural) 3 Yes Yes Hormonal/unknown
2 Cerebellum (Dural) unknown Unknown Yes Unknown
3 Frontal Lobe (Dural) 14 Yes Yes Hormonal and cytotoxic
4 Parieto-occipital (Dural) 3 Yes Yes Hormonal
5 L4 (Dural) 10 Yes Yes Hormonal, cytotoxic and immunotherapy
6 Cerebellum (Dural) 4 Yes Yes Hormonal and cytotoxic
7 T-spine (Dural) unknown Yes Yes Unknown
8 C7 (Dural) 9 Yes Yes Hormonal and cytotoxic
9 Occipital (Parenchymal) 3 Yes Yes Hormonal, cytotoxic and immunotherapy
10 Thalamus (Parenchymal) 12 Yes Yes Hormonal and cytotoxic
11 Temporal (Parenchymal) 2 Yes Yes Hormonal and cytotoxic
12 Cerebellum (Parenchymal) 0 Yes No Orchiectomy only (hospice)
13 Sellar Region (Parenchymal) unknown Yes Yes Unknown
14 T10–11 (Dural) 3 Yes Yes Hormonal and cytotoxic
15 Frontotemporal (Dural) 14 Yes Yes Hormonal and cytotoxic
16 T6–7 (Dural) 2 Yes Yes Hormonal and cytotoxic
17 Frontoparietal (Dural) 26 Yes Yes Hormonal and cytotoxic
18 T8–10 (Dural) 13 Yes Yes Hormonal and cytotoxic
19 T8 (Dural) 3 Yes Yes Hormonal, cytotoxic and immunotherapy
20 T1–4 (Dural) 6 Yes Yes Hormonal and cytotoxic
21 Not specified (Dural) unknown Unknown Yes Unknown